GPR132 and neoplasm: Lysophosphatidylcholine binds to G protein-coupled receptors (G2A/GPR4), activating signaling pathways that promote cancer cell proliferation, migration, and survival, thereby enhancing tumor invasiveness and metastasis (Xu, 2002).